Table 1.
Dynamics of patients’ characteristics.
| Parameter | Baseline Values | Changes after 6 Months | Δ* | p-Value |
|---|---|---|---|---|
| Weight (kg) | 99.15 ± 16.07 | 94.13 ± 14.81 | −5 | <0.001 * |
| BMI (kg/m2) | 34.55 ± 4.79 | 32.85 ± 4.76 | −1.7 | <0.001 * |
| Waist (cm) | ||||
| Men | 115.03 ± 12.30 | 112.93 ± 11.71 | −2.1 | 0.02 * |
| Women | 115.05 ± 10.03 | 114.75 ± 11.23 | - | 0.92 |
| TC (mg/dL) | 192.58 ± 61.68 | 184.43 ± 46.45 | - | 0.45 |
| TG (mg/dL) | 171 (55; 887) | 143 (58; 1397) | - | 0.29 |
| HDLc (mg/dL) | ||||
| Men | 38 (17; 89) | 42 (19; 90) | +4 | 0.01 * |
| Women | 39.90 ± 12.14 | 45.15 ± 12.82 | - | 0.19 |
| LDLc (mg/dL) | 107 (50; 262) | 96 (33; 202) | - | 0.18 |
| Uric acid (mg/dL) | 5.16 ± 1.28 | 4.72 ± 1.11 | - | 0.07 |
| Glycemia (mg/dL) | 197 (93; 438) | 155 (74; 294) | −42 | <0.001 * |
| HbA1c (%) | 8.66 ± 1.18 | 7.86 ± 1.26 | −0.8 | 0.001 * |
| EFV (cm3) | 37.80 ± 17.22 | 20.73 ± 7.09 | −17.1 | <0.001 * |
| L4VFV (cm3) | 39.18 ± 29.17 | 43.27 ± 18.43 | - | 0.39 |
| AIP | 0.28 ± 0.33 | 0.20 ± 0.34 | −0.08 | 0.04 * |
| CRR | 4.77 (2.27; 13.08) | 3.89 (2.03; 11.47) | −0.9 | 0.04 * |
| AC | 3.77 (1.27; 12.08) | 2.89 (1.03; 10.47) | −0.9 | 0.04 * |
| TyG index | 5.24 ± 0.39 | 5.03 ± 0.37 | −0.2 | 0.01 * |
| VAI | ||||
| Women | 3.32 (1.27; 14.69) | 3.15 (1.14; 29.34) | - | 0.44 |
| Men | 2.81 (0.96; 22.58) | 2.21 (0.47; 43.90) | - | 0.20 |
| Conicity index | 1.38 ± 0.08 | 1.40 ± 0.07 | +0.1 | 0.03 * |
| CAP (Db/m) | 361 (240; 400) | 310 (190; 400) | −51 | <0. 001 * |
| Fibroscan (kPa) | 6.95 (3.50; 43.80) | 6.40 (3.30; 15.30) | - | 0.09 |
* The differences are statistically significant. Continuous nonparametric numerical variables with distribution expressed as median and [interquartile range]. The results of the normal distributed variables are expressed as mean ± standard deviation. Δ* = significant differences between baseline and 6-month follow-up; BMI = body mass index; Waist = abdominal circumference; TC = total cholesterol; TG = triglyceride; HDLc = high-density lipid cholesterol; LDLc = low-density lipid cholesterol; HbA1c = glycated hemoglobin; EFV = epicardial fat volume; L4VFV = visceral fat volume at the fourth vertebrae; AIP = atherogenic index plasma; CRR = cardiac risk ratio; AC = atherogenic coefficient; TyG = product of triglycerides and glucose; VAI = visceral adiposity index; CAP = controlled attenuation parameter; Fibroscan = liver stiffness score.